Lab21 Company Profile
Lab21 is a global leader in personalised healthcare. It provides diagnostic products and services and supports blood bank screening, medical diagnostics and drug discovery. Lab21 customers include international healthcare providers, pharmaceutical and diagnostic companies. The Products division of Lab21 manufactures immunodiagnostic kits and reagents that are distributed internationally and is focused on infectious diseases for the blood-banking and clinical markets. Our clinical services operations has a growing test portfolio providing companion diagnostics and high technology molecular assays. Lab21's corporate offices are based in Cambridge, UK and South Carolina, with a GMP manufacturing site in Cambridge and other manufacturing facilities in Newmarket, Camberley and Bridport. The Company's investors include Excalibur, Nexus Medical Partners and Medicis Capital. Website: www.lab21.com
Trinity Biotech PLC (clinical lab and point-of-care diagnostics) paid $7.59mm in cash for personalized medicine firm Lab21 Ltd.’s blood bank screening and certain molecular assets.
Drugs and Medications
Lab21 is a global leader in personalised healthcare. It provides diagnostic products and services and supports blood bank screening, medical diagnostics and drug discovery. Lab21...
More Information about "Lab21" on BioPortfolio
We have published hundreds of Lab21 news stories on BioPortfolio along with dozens of Lab21 Clinical Trials and PubMed Articles about Lab21 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lab21 Companies in our database. You can also find out about relevant Lab21 Drugs and Medications on this site too.